Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
Kharfan-Dabaja, Mohamed, Rahul Mhaskar, Tea Reljic, Joseph Pidala, Janelle B Perkins, Benjamin Djulbegovic, and Ambuj Kumar. 2014. “Mycophenolate Mofetil versus Methotrexate for Prevention of Graft-versus-Host Disease in People Receiving Allogeneic Hematopoietic Stem Cell Transplantation.”. The Cochrane Database of Systematic Reviews 2014 (7): CD010280.